Health Catalyst down as Piper Sandler adds to downgrades on Q2 results

2 hours ago 1

Healthcare

Comments

Wall Street sign in Lower Manhattan, NYC

Health Catalyst (NASDAQ:HCAT) traded lower in the morning hours on Wednesday, ending a four-day winning streak after Piper Sandler became the latest brokerage to downgrade the South Jordan, Utah-based Health Tech, citing its recent Q2 2025 results.

Analyst Jessica Tassan

Recommended For You

More Trending News

Read Entire Article

Health Catalyst down as Piper Sandler adds to downgrades on Q2 results

Recommended For You

More Trending News

Related

‘It’s getting pretty scary’: The Colorado River, 40 million ...

MASH drug developers rise as FDA accepts lenient trial requi...

Caribbean Utilities declares $0.19 dividend

Germany hopes it can build up its Army by asking young peopl...

Videogame sales rise 5% as EA Sports, Nintendo, mobile lift ...

Melania Trump wants you to use AI to solve your community is...

Turkey's Erdogan inaugurates $1.5B R&D hub to bolster defens...

Insider buying boosts Coty shares

Williams-Sonoma outlines 2% to 5% 2025 comp revenue growth t...

Romania, Rheinmetall to build $622M munitions powder plant

Biogen wins approval of postpartum depression drug Zurzuvae ...

RWE's Krebber says no need for U.S. wind project writedown d...

Luckin Coffee attracts positive early reviews in New York Ci...

Philippine telecom law increases regulatory pressure on PLDT...

FDA authorizes updated Covid-19 shots, but with restrictions...

Relieved Kohl’s investors give the stock a 20% boost—but the...

Hormel Foods FQ3 2025 Earnings Preview

Best Buy FQ2 2026 Earnings Preview

EQT in talks with NextDecade for LNG supply from Texas proje...

FHA allows Fannie Mae, Freddie Mac to approve Rocket Cos.-Mr...

Trending

Popular

Blue Moon Metals gets $400M project finance

Brandon Blackstock’s Daughter Savannah Breaks Silence on Fat...